PHYSICIANS

Dr.Barake is a consultant physician in Endocrinology & Metabolism.

She pursued her undergraduate studies and medical school at the American University of Beirut, Lebanon. She then did her internal medicine residency and endocrinology fellowship at the American University of Beirut, Medical Center, after which she completed a one-year specialized fellowship in Pituitary Disorders at the Neuroendocrine Clinical Center, Massachusetts General Hospital, Harvard Medical School. In return to Lebanon, she pursued a Masters Degree in Health Research at the American University of Beirut Scholars in Health Research Program.

During her training, Dr.Barake received several awards, among which the Endocrinology Excellence Award in Research for 2 consecutive years. In 2010, she was elected to the prestigious Alpha Omega Alpha Honor Medical Society. Dr.Barake is certified in Endocrinology & Diabetes by the Royal College of Physicians, UK. She holds as well an international certification in the evaluation of bone densitometry by the International Society of Clinical Densitometry and an international certification in the management of obesity by the Strategic Centre for Obesity Professional Education of the World Obesity Federation.

In parallel to her clinical practice in Endocrinology, Dr.Barake holds several key positions in international and local medical societies. She is a founding member of the Gulf & Lebanon steering committee of the World Obesity Federation and is an expert member of the Obesity Recommendations Group of the same committee. She is part of the Executive Committee of the Lebanese Society of Endocrinology, Diabetes & Lipids and is an active member of both the National Obesity Campaign Committee and the National Diabetes Campaign Committee of the Lebanese Ministry of Public Health.

Dr.Barake’s research interests are namely in the fields of obesity, bone disorders and pituitary disorders, on which she has published in peer-reviewed journals, including the Journal of Clinical Endocrinology & Metabolism, Pituitary and Endocrine.
 

Endocrinologist, Clemenceau Medical Center, 2014 - present

Degrees:
- Masters of Science, Health Research, 2013-2016
Scholars in HeAlth Research Program, American University of Beirut, Lebanon

- Fellowship in Pituitary Diseases, 2011-2012
Massachusetts General Hospital, Harvard Medical School, USA

- Fellowship in Endocrinology & Metabolism, 2009-2011
American University of Beirut, Medical Center, Lebanon

- Residency in Internal Medicine, 2006-2009
American University of Beirut, Medical Center, Lebanon

- Medical Doctor Degree, 2002-2006
American University of Beirut, Lebanon

- Bachelor of Science, Biology, 1999-2002
American University of Beirut, Lebanon

Original Articles
1- Barake, M, Klibanski A, Tritos NA. Impulse control disorders in patients with hyperprolactinemia treated with dopamine agonists: How much should we worry? Eur J Endocrinol 2018 179(6): 287-296

2- Barake M, Arabi A, Nakhoul N, El Hajj Fuleihan G, El Ghandour S, Klibanski A, Tritos NA. Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis. Endocrine 2018 59(1): 39-49

3- Barake M, Tritos NA. Evaluation and management of thyrotropin-secreting pituitary adenomas. Int J Endo Oncol 2014 1(2): 163-171

4- Ajmal A, Haghshenas A, Attarian S, Barake M, Tritos NA, Klibanski A, Miller KK, Nachtigall LB. The Effect of Somatostatin Analogs on Vitamin D and Calcium Concentrations in Patients with Acromegaly. Pituitary 2014 Aug; 17(4): 366-73

5- Barake M, Evins AE, Stoeckel L, Pachas GN, Nachtigall LB, Miller KK, Biller BM, Tritos NA, Klibanski A. Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary 2014 April; 17(2): 150-6 

6- Barake M, Klibanski A, Tritos NA. Effects of Recombinant Human Growth Hormone Therapy on BMD in Adults with Growth Hormone Deficiency: A Meta-analysis. J Clin Endocrinol Metab. 2014 Mar; 99(3): 852-60

7- Barake M, Daher RT, Salti I, Cortas NK, Al-Shaar L, Habib RH, Fuleihan G El-H. 25-Hydroxyvitamin D Assay Variations and Impact on Clinical Decision Making. J Clin Endocrinol Metab. 2012 Mar; 97(3): 835-43

8- Seif FE, Azar S, Barake M, Sawaya R. Hypercalcemia in Glioblastoma Multiforme. Neuro Endocrinol Lett. 2006 Aug; 27(4): 547-8 

   
  Book Chapter

Barake M, Tritos NA. The Pituitary. Textbook of Internal Medicine: An Intensive Board Review Book. Baliga RR (Ed). March 2018
  Poster Presentation

1- Sawan C, Salloum C, Nachanakian A, Barake M. TSH-Producing Adenoma: Residual Tumor Treated with Once Monthly Octreotide. ENDO 2018. Chicago, USA

2- Nachtigall L, Attarian S, Barake M, Tritos N, Klibanski A, Miller K. The Effect of Somatostatin Analogs on serum Calcium and 25-Hydroxyvitamin D Concentrations in Patients with Acromegaly: A Retrospective Study of 119 Patients. ENDO 2012. Houston, USA

3- Barake M, Salti H, Haddad T, Bou Khalil R, Salti I, Taleb N, Kobeissy A, Nasrallah M. One year change in metabolic control in a cohort of type 2 diabetic subjects at the American University of Beirut, Lebanon. World Diabetes Congress, International Diabetes Federation. Montreal, Canada